These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29150217)

  • 1. Idiopathic macular telangiectasia type 2: Prevalence and a morphometric and phenotypic study.
    Bayón-Porras RM; Pascual-Camps I; Plaza-Laguardia C; Gallego-Pinazo R
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Mar; 93(3):105-112. PubMed ID: 29150217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choroidal thickness and vascular density in macular telangiectasia type 2 using
    Wang JC; Laíns I; Oellers P; Kim IK; Miller JW; Miller JB
    Br J Ophthalmol; 2019 Nov; 103(11):1584-1589. PubMed ID: 30602449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive multi-imaging biomarkers relevant for visual acuity in idiopathic macular telangiectasis type 1.
    Guo J; Tang W; Ye X; Wu H; Xu G; Liu W; Zhang Y
    BMC Ophthalmol; 2018 Mar; 18(1):69. PubMed ID: 29506510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
    Ayachit AG; Reddy LU; Joshi S; Ayachit GS
    Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2.
    Roisman L; Rosenfeld PJ
    Dev Ophthalmol; 2016; 56():146-58. PubMed ID: 27022942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
    Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological characteristics preceding exudative neovascularisation secondary to macular telangiectasia type 2.
    Hess K; Charbel Issa P; Holz FG; Tzaridis S
    Br J Ophthalmol; 2022 Dec; 106(12):1736-1741. PubMed ID: 34167944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OCT Angiography Helps Distinguish Between Proliferative Macular Telangiectasia Type 2 and Neovascular Age-Related Macular Degeneration.
    Zheng F; Motulsky EH; de Oliveira Dias JR; de López EP; Gregori G; Rosenfeld PJ
    Ophthalmic Surg Lasers Imaging Retina; 2018 May; 49(5):303-312. PubMed ID: 29772040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "En face" optical coherence tomography imaging in type 2 idiopathic macular telangiectasia.
    Wolff B; Basdekidou C; Vasseur V; Sahel JA; Gaudric A; Mauget-Faÿsse M
    Retina; 2014 Oct; 34(10):2072-8. PubMed ID: 25255245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic and Multimodal Imaging Features of Macular Telangiectasia Type 2: Korean Macular Telangiectasia Type 2 Study - Report No. 2.
    Kim YH; Chung YR; Oh J; Kim SW; Lee CS; Yun C; Lee B; Ahn SM; Choi EY; Jang S; Lee K
    Ophthalmic Epidemiol; 2021 Oct; 28(5):436-443. PubMed ID: 33459094
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.
    Roller AB; Folk JC; Patel NM; Boldt HC; Russell SR; Abramoff MD; Mahajan VB
    Retina; 2011 Oct; 31(9):1848-55. PubMed ID: 21610563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A.
    Chhablani J; Rao HB; Begum VU; Jonnadulla GB; Goud A; Barteselli G
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1416-22. PubMed ID: 25655800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectral-domain optical coherence tomography measurements of choroidal thickness and outer retinal disruption in macular telangiectasia type 2.
    Nunes RP; Goldhardt R; de Amorim Garcia Filho CA; Thorell MR; Abbey AM; Kuriyan AE; Modi YS; Shah M; Yehoshua Z; Gregori G; Feuer W; Rosenfeld PJ
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):162-70. PubMed ID: 25707040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2.
    Zhang Q; Wang RK; Chen CL; Legarreta AD; Durbin MK; An L; Sharma U; Stetson PF; Legarreta JE; Roisman L; Gregori G; Rosenfeld PJ
    Retina; 2015 Nov; 35(11):2285-99. PubMed ID: 26457402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab for type 2 idiopathic macular telangiectasia.
    Veloso CE; Vianna RN; Pelayes DE; Nehemy MB
    Ophthalmic Res; 2013; 49(4):205-8. PubMed ID: 23364325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OCT Angiography Findings of Tamoxifen Retinopathy: Similarity with Macular Telangiectasia Type 2.
    Lee S; Kim HA; Yoon YH
    Ophthalmol Retina; 2019 Aug; 3(8):681-689. PubMed ID: 31068263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radial Hemorrhage in Henle Layer in Macular Telangiectasia Type 2.
    Au A; Hou K; Baumal CR; Sarraf D
    JAMA Ophthalmol; 2018 Oct; 136(10):1182-1185. PubMed ID: 30054619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography.
    Park YG; Park YH
    PLoS One; 2020; 15(4):e0232255. PubMed ID: 32348375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic features of idiopathic macular telangiectasia in Korean patients.
    Kim SH; Oh J; Ahn SE; Park CY; Oh JH
    Korean J Ophthalmol; 2015 Jun; 29(3):155-9. PubMed ID: 26028942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OCT-angiography for diagnosis and response to treatment of subretinal neovascularization secondary to idiopathic macular telangiectasia type 2.
    Tapia Quijada HE; Mantolan Sarmiento C; Gómez Perera S; Serrano García M; Betancor Caro N; Haro Álvarez B
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Apr; 97(4):224-229. PubMed ID: 35523469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.